Stephen Kilmer
Investor Relations
Replay available
BioRestorative Therapies, Inc. (NASDAQ: BRTX) Q2 2024 earnings conference call, held 2024-08-13. Replay captured from the company's public earnings webcast.

Investor Relations
Chairman and Chief Executive Officer
Chief Financial Officer
Vice President of Research and Development
Analyst, Roth MKM
Analyst, Maxim Group
Analyst, Rodman & Renshaw
Private Investor
Watch the replay and follow the connected company analysis, news, and investor updates for Biorestorative Therapies, Inc..
WEBVTT 00:00:00.029 -- 00:00:05.092 Good afternoon and welcome to the Biorestorative Therapies second 00:00:05.092 -- 00:00:07.593 quarter 2024 Investor 00:00:07.593 -- 00:00:12.755 Call. At this time, all participants are in a listen-only mode and we will 00:00:12.755 -- 00:00:15.637 open for questions following the presentation. 00:00:15.637 -- 00:00:20.599 If anyone should require operator assistance during the conference, please press star 00:00:20.599 -- 00:00:25.142 zero on your phone keypad. Please note this conference is being recorded. 00:00:25.142 -- 00:00:30.620 I will now turn the conference over to your host, Stephen Kilmer, Investor Relations. 00:00:30.620 -- 00:00:33.920 Stephen, the floor is yours. 00:00:33.981 -- 00:00:38.803 Thank you. Good afternoon, everyone. Let me start by pointing out that this conference 00:00:38.803 -- 00:00:42.665 call will include forward-looking statements within the meaning of the Private Securities 00:00:42.665 -- 00:00:45.855 Litigation Reform Act of 1995. 00:00:46.046 -- 00:00:49.987 All forward-looking statements are based on biorestorative therapy's current beliefs, 00:00:49.987 -- 00:00:55.066 assumptions, and expectations. And such statements involve known and unknown risks, uncertainties, 00:00:55.066 -- 00:00:59.488 and other factors that may cause actual results, performance, or achievements to be materially 00:00:59.488 -- 00:01:02.329 different from those implied by such statements. 00:01:02.329 -- 00:01:04.850 No forward-looking statement can be guaranteed. 00:01:04.850 -- 00:01:09.832 For details on factors, among others, that could affect expectations, see Part 1, Item 00:01:09.832 -- 00:01:14.794 1A of our annual report on Form 10-K for the year ended December 31, 2023, filed with 00:01:14.794 -- 00:01:19....